Description
RAPIDGLIM M4-500 contains Glimepiride and Metformin Hydrochloride Sustained Release Tablets IP. This combination helps manage blood sugar levels in adults with Type 2 Diabetes Mellitus when prescribed by a qualified healthcare professional.
Glimepiride helps the pancreas release insulin. Metformin helps reduce glucose production in the liver and improves the body’s response to insulin. Therefore, the two medicines work through different actions to support blood glucose control.
Brand Name: RAPIDGLIM M4-500
Composition: Glimepiride + Metformin Hydrochloride Sustained Release Tablets IP
Dosage Form: Sustained Release Tablets
Therapeutic Category: Antidiabetic Medicine
Indication: Type 2 Diabetes Mellitus
Company: Rapid Life Drugs & Healthcare
Glimepiride + Metformin Hydrochloride Sustained Release Tablets IP
Glimepiride + Metformin Hydrochloride Sustained Release Tablets IP combine two antidiabetic medicines in one tablet. Doctors may prescribe this combination when diet, exercise and single-drug therapy do not provide adequate blood sugar control.
Glimepiride belongs to the sulfonylurea class. It increases insulin release from the pancreas. On the other hand, Metformin belongs to the biguanide class. It mainly reduces glucose production by the liver and improves insulin sensitivity.
The sustained-release form of Metformin releases the medicine gradually. As a result, it provides prolonged action according to the prescribed treatment plan.
Uses of RAPIDGLIM M4-500
Doctors may prescribe RAPIDGLIM M4-500 to:
- Manage Type 2 Diabetes Mellitus
- Improve blood glucose control
- Support diabetes treatment along with diet and exercise
- Provide combination therapy when required
- Help patients who need more than one antidiabetic medicine
However, this combination is not intended as a standard treatment for Type 1 Diabetes Mellitus or diabetic ketoacidosis.
How Does RAPIDGLIM M4-500 Work?
Glimepiride
Glimepiride stimulates the pancreas to release insulin. The increased insulin helps the body lower elevated blood glucose levels.
Metformin Hydrochloride
Metformin reduces glucose production in the liver. It also improves the body’s response to insulin. Consequently, the body can use glucose more effectively.
Sustained-Release Metformin
The sustained-release formulation releases Metformin gradually. Therefore, patients should take the tablet exactly as prescribed. Do not crush or chew a sustained-release tablet unless the product information or doctor specifically allows it.
Benefits of Glimepiride + Metformin Tablets
RAPIDGLIM M4-500 provides two complementary antidiabetic actions:
- Helps support better blood glucose control
- Combines Glimepiride and Metformin in one formulation
- Supports Type 2 Diabetes management
- Includes Metformin in sustained-release form
- Can complement a healthy diet and regular physical activity
- Offers convenient combination therapy when prescribed
Dosage and Administration
Take RAPIDGLIM M4-500 only according to your doctor’s prescription. The appropriate dose depends on your blood glucose levels, medical history, kidney function and response to treatment.
Take the tablet with water and follow the prescribed schedule. Do not change the dose or stop treatment without medical advice.
Because this is a sustained-release formulation, swallow the tablet whole unless your doctor or product leaflet provides different instructions.
Possible Side Effects
Some patients may experience side effects while taking Glimepiride and Metformin. These may include:
- Nausea
- Diarrhea
- Stomach discomfort
- Loss of appetite
- Headache
- Dizziness
- Low blood sugar
Side effects can vary between patients. Contact your doctor if any reaction becomes severe, persistent or unusual.
Precautions
Before starting RAPIDGLIM M4-500, tell your doctor about your medical history. Also, provide information about all medicines and supplements you currently use.
Your doctor may need to monitor you carefully if you have:
- Kidney problems
- Liver problems
- A history of low blood sugar
- Excessive alcohol use
- Conditions that may cause dehydration
- A risk of vitamin B12 deficiency
Glimepiride can cause hypoglycemia, or low blood sugar. Therefore, learn to recognize symptoms such as sweating, shaking, hunger, dizziness and confusion.
Metformin can rarely cause lactic acidosis. The risk may increase in people with severe kidney impairment and certain other medical conditions.
Why Choose RAPIDGLIM M4-500 from Rapid Life Drugs & Healthcare?
Rapid Life Drugs & Healthcare offers pharmaceutical products across several therapeutic categories. RAPIDGLIM M4-500 – Glimepiride + Metformin Hydrochloride Sustained Release Tablets IP is part of its antidiabetic product portfolio.
The formulation combines two medicines that work through different mechanisms to support blood glucose management in appropriate patients with Type 2 Diabetes Mellitus.
For product information, availability and pharmaceutical business enquiries, contact Rapid Life Drugs & Healthcare.
Frequently Asked Questions
What is RAPIDGLIM M4-500?
RAPIDGLIM M4-500 is a combination formulation containing Glimepiride + Metformin Hydrochloride Sustained Release Tablets IP. It is used for the management of Type 2 Diabetes Mellitus when prescribed by a doctor.
What is the composition of RAPIDGLIM M4-500?
RAPIDGLIM M4-500 contains Glimepiride and Metformin Hydrochloride in sustained-release form. Please verify the exact Glimepiride and Metformin strengths from the approved product specification before publishing.
What is Glimepiride + Metformin used for?
Doctors use this combination to help manage blood glucose levels in adults with Type 2 Diabetes Mellitus, together with appropriate diet and exercise.
How does Glimepiride work?
Glimepiride stimulates the pancreas to release insulin. This helps lower elevated blood glucose levels.
How does Metformin work?
Metformin reduces glucose production by the liver. It also improves insulin sensitivity, which helps the body use glucose more effectively.
Is RAPIDGLIM M4-500 a prescription medicine?
Yes. Use RAPIDGLIM M4-500 only under the guidance of a qualified healthcare professional.
Can RAPIDGLIM M4-500 be used for Type 1 Diabetes?
This combination is generally intended for Type 2 Diabetes Mellitus. It is not a standard treatment for Type 1 Diabetes.
About Rapid Life Drugs & Healthcare
Rapid Life Drugs & Healthcare is a pharmaceutical company offering products across different therapeutic segments. Its portfolio includes formulations for diabetes and other healthcare requirements.
For enquiries regarding RAPIDGLIM M4-500, product availability and pharmaceutical business opportunities, contact Rapid Life Drugs & Healthcare.
